Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Plos One
|
April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One
|
October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 27, 2025
Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques
Irene Victoria Bermúdez-Pérez, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2018
The influence of drug properties and host factors on delayed onset of symptoms in drug-induced liver injury
Andres Gonzalez-Jimenez, Kristin McEuen, Minjun Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
Miguel E Zoubek, Andres González-Jimenez, Inmaculada Medina-Cáliz, et al.
Frontiers in Pharmacology
|
September 13, 2016
Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients
Camilla Stephens, Antonia Moreno-Casares, Miguel-Ángel López-Nevot, et al.
British Journal of Clinical Pharmacology
|
March 26, 2025
Epigenetic modifications in drug-induced liver injury: A systematic review
Romina Lorena de Los Santos-Fernández, Antonio Segovia-Zafra, Guillermo Paz-López, et al.
British Journal of Pharmacology
|
June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)
Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
Sara Román-Sagüillo, Raisa Quiñones Castro, María Juárez-Fernández, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
Eugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Plos One
|
April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One
|
October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 27, 2025
Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques
Irene Victoria Bermúdez-Pérez, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2018
The influence of drug properties and host factors on delayed onset of symptoms in drug-induced liver injury
Andres Gonzalez-Jimenez, Kristin McEuen, Minjun Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
Miguel E Zoubek, Andres González-Jimenez, Inmaculada Medina-Cáliz, et al.
Frontiers in Pharmacology
|
September 13, 2016
Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients
Camilla Stephens, Antonia Moreno-Casares, Miguel-Ángel López-Nevot, et al.
British Journal of Clinical Pharmacology
|
March 26, 2025
Epigenetic modifications in drug-induced liver injury: A systematic review
Romina Lorena de Los Santos-Fernández, Antonio Segovia-Zafra, Guillermo Paz-López, et al.
British Journal of Pharmacology
|
June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)
Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
Sara Román-Sagüillo, Raisa Quiñones Castro, María Juárez-Fernández, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
Eugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Page
of 6